由circSpdyA编码的127aa促进了乳腺癌中的FA合成和NK细胞抑制
Xinya Gao1,2, Zicheng Sun1,2, Xin Liu1,2
1Department of Breast and Thyroid Surgery, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, 510080, China.
Cell death and differentiation
|October 14, 2024
概括
一种新型circRNA,circSpdyA,产生一种微 (127aa),通过增强脂肪酸合成来促进乳腺癌的生长,并通过抑制自然杀手 (NK) 细胞活性来抑制抗瘤免疫力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 脂质新陈代谢的重编程对于乳腺癌的进展和免疫规避至关重要.
- 癌症中这种代谢转变的机制和调节者仍然未被充分探索.
研究的目的:
- 在乳腺癌中识别调节脂质代谢的新型circRNAs.
- 调查已识别的circRNA及其编码在瘤发生和免疫逃脱中的作用.
主要方法:
- 建立了以标准和高脂肪饮食治疗乳腺癌的小鼠模型.
- 执行circRNA测序以识别差异表达的circRNAs.
- 利用单细胞测序来分析免疫细胞透和功能.
- 研究了分子机制,包括表观遗传调节和蛋白质-蛋白质相互作用.
主要成果:
- CircSpdyA被显著上调,并编码一个微,127aa.
- 127aa通过直接结合FASN (脂肪酸合成酶) 来增强新型脂肪酸合成,促进乳腺癌细胞的增殖.
- 127aa通过表观遗传抑制NK细胞激活剂转录来抑制自然杀手 (NK) 细胞的透和功能,并且从癌细胞转移脂质进一步降低NK细胞的细胞毒性.
结论:
- CircSpdyA编码的127aa是一种通过脂肪酸合成促进乳腺癌生长的关键调节剂.
- 127aa通过抑制NK细胞活性,促进免疫逃避,突出其作为治疗点的潜力.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
09:24Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
9.0K
相关概念视频
Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
NF-κB-dependent Signaling Pathway
7.3K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.3K
